Gallagher; Peter Thaddeus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gallagher; Peter Thaddeus.The latest application filed is for "(thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists".

Company Profile

0.16.15

Gallagher; Peter Thaddeus - Yateley GB
Gallagher; Peter Thaddeus - Hampshire GB
Gallagher; Peter Thaddeus - Basingstoke GB
Gallagher; Peter Thaddeus - Surrey GB
Gallagher; Peter Thaddeus - Basingstokes GB
Gallagher; Peter Thaddeus - Camberley GB2

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT.sub.2A antagonists Grant 9,562,057 - Gallagher February 7, 2	2017-02-07
(THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS App 20150353576 - GALLAGHER; Peter Thaddeus	2015-12-10
Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylp- ropanoic acid compounds as dual activity H1 inverse agonists/5-HT.sub.2A antagonists Grant 8,314,092 - Camp , et al. November 20, 2	2012-11-20
SUBSTITUTED [(5H-PYRROLO[2,1-c][1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLP- ROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS App 20120202797 - CAMP; Anne Marie ; et al.	2012-08-09
2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists Grant 8,202,873 - Badescu , et al. June 19, 2	2012-06-19
5-HT7 receptor antagonists Grant 7,910,588 - Badescu , et al. March 22, 2	2011-03-22
5-ht7 Receptor Antagonists App 20100197700 - Badescu; Valentina O ; et al.	2010-08-05
2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl Pyrazines And Pyridines And 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl Pyridines As 5-ht7 Receptor Antagonists App 20100120785 - Badescu; Valentina O. ; et al.	2010-05-13
3-Aminopyrrolidines as inhibitors of monoamine uptake Grant 7,619,096 - Beadle , et al. November 17, 2	2009-11-17
Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake Grant 7,615,648 - Harris , et al. November 10, 2	2009-11-10
Morpholine derivatives as norepinephrine reuptake inhibitors Grant 7,595,315 - Gallagher , et al. September 29, 2	2009-09-29
4-Amino-piperidine derivatives as monoamine uptake inhibitors Grant 7,521,462 - Boulet , et al. April 21, 2	2009-04-21
Pyridinylmorpholine derivatives Grant 7,488,728 - Clark , et al. February 10, 2	2009-02-10
3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake Grant 7,432,280 - Beadle , et al. October 7, 2	2008-10-07
3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake Grant 7,417,064 - Boulet , et al. August 26, 2	2008-08-26
3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake Grant 7,410,996 - Boulet , et al. August 12, 2	2008-08-12
Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors Grant 7,410,982 - Boulet , et al. August 12, 2	2008-08-12
2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors Grant 7,384,941 - Walter , et al. June 10, 2	2008-06-10
Aminomethyl-Azacycle Derivatives as Inhibitors of Monoamine Uptake App 20080004330 - Harris; John Richard ; et al.	2008-01-03
Benzyl morpholine derivatives Grant 7,294,623 - Clark , et al. November 13, 2	2007-11-13
4-Amino-piperidine derivatives as monoamine uptake inhibitors App 20070093526 - Boulet; Serge Louis ; et al.	2007-04-26
3-Aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake App 20070066663 - Beadle; Christopher David ; et al.	2007-03-22
Morpholine derivatives as norepinephrine reuptake inhibitors App 20070060585 - Gallagher; Peter Thaddeus ; et al.	2007-03-15
3-Aminopyrrolidines as inhibitors of monoamine uptake App 20060270713 - Beadle; Christopher David ; et al.	2006-11-30
Pyridinylmorpholine derivatives App 20060258654 - Clark; Barry Peter ; et al.	2006-11-16
Inhibitors of monomine uptake App 20060079554 - Barry; Peter Clark ; et al.	2006-04-13
Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors App 20060058360 - Boulet; Serge Louis ; et al.	2006-03-16
Benzyl morpholine derivatives App 20060052377 - Clark; Barry Peter ; et al.	2006-03-09
Morpholine derivatives App 20060035894 - Walter; Magnus Wilhelm ; et al.	2006-02-16
3-Aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norephinephrine reuptake App 20060014779 - Boulet; Serge Louis ; et al.	2006-01-19
Pharmaceutical compounds Grant 5,663,375 - Brunavs , et al. September 2, 1	1997-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.